CARDIOVASCULAR PHARMACEUTICALS ATRIAL FIBRILLATION

Brand Owner (click to sort) Address Description
ATRISET ASTELLAS US 1 Astellas Way Northbrook IL 60062 Cardiovascular pharmaceuticals for atrial fibrillation and atrial flutter;
KADENZA ASTELLAS US 1 Astellas Way Northbrook IL 60062 Cardiovascular pharmaceuticals for atrial fibrillation and atrial flutter;
KYNAPID ASTELLAS US 1 Astellas Way Northbrook IL 60062 Cardiovascular pharmaceuticals for atrial fibrillation and atrial flutter;
RAPASYM ASTELLAS US 1 Astellas Way Northbrook IL 60062 Cardiovascular pharmaceuticals for atrial fibrillation and atrial flutter;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Systems and techniques for monitoring cardiac activity. In one aspect, a method includes collecting information describing the variability in heart rate over a series of beats, designating variability at a lower end of physiological values as being largely irrelevant to atrial fibrillation, designating variability in a midrange of physiological values as being indicative of atrial fibrillation, designating variability in an upper range of physiological values as being negatively indicative of atrial fibrillation, and determining a relevance of the variability described in the collection to atrial fibrillation.